Alpha-1 antitrypsin in autoimmune diseases: Roles and therapeutic prospects

被引：6

作者：

Sun, Rui ^{[1
,2
]}

Xu, Zhiqiang ^{[3
,4
]}

Zhu, Chenxi ^{[1
,2
]}

Chen, Tao ^{[1
,2
]}

Munoz, Luis E. ^{[5
,6
]}

Dai, Lunzhi ^{[3
,4
]}

Zhao, Yi ^{[1
,2
]}

机构：

[1] Sichuan Univ, West China Hosp, Dept Rheumatol & Immunol, Chengdu, Peoples R China

[2] Sichuan Univ, West China Hosp, Clin Inst Inflammat & Immunol CIII, Frontiers Sci Ctr Dis Related Mol Network, Chengdu, Sichuan, Peoples R China

[3] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Dept Rheumatol & Immunol, Chengdu, Peoples R China

[4] Sichuan Univ, West China Hosp, Dept Gen Practice, State Key Lab Biotherapy, Chengdu, Peoples R China

[5] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Internal Med Rheumatol & Immunol 3, Erlangen, Germany

[6] Univ Klinikum Erlangen, Erlangen, Germany

来源：

INTERNATIONAL IMMUNOPHARMACOLOGY | 2022年 / 110卷

关键词：

-1 antitrypsin; A1AT; Autoimmune diseases; AATD; Treatment; OBSTRUCTIVE PULMONARY-DISEASE; ADDITIONAL N-GLYCOSYLATION; ISLET AMYLOID POLYPEPTIDE; HUMAN MONOCYTE ACTIVATION; NEUTROPHIL ELASTASE; GENE-THERAPY; AUGMENTATION THERAPY; ALPHA-ANTITRYPSIN; ALPHA(1)-ANTITRYPSIN DEFICIENCY; RHEUMATOID-ARTHRITIS;

D O I：

10.1016/j.intimp.2022.109001

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Alpha-1 antitrypsin (A1AT) is a protease inhibitor in the serum. Its primary function is to inhibit the activity of a series of proteases, including proteinase 3, neutrophil elastase, metalloproteases, and cysteine-aspartate proteases. In addition, A1AT also has anti-inflammatory, anti-apoptotic, anti-oxidative stress, anti-viral, and antibacterial activities and plays essential roles in the regulation of tissue repair and lymphocyte differentiation and activation. The overactivation of the immune system characterizes the pathogenesis of autoimmune diseases. A1AT treatment shows beneficial effects on patients and animal models with autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus. This review summarizes the functions and therapeutic prospects of A1AT in autoimmune diseases.

引用

页数：12

共 50 条

[1] Alpha-1 antitrypsin: Associated diseases and therapeutic uses
Kandregula, Chaya A. Babu
Aseervatham, Smilin Bell G.
Bentley, Gary T.
Kandasamy, Ruckmani
CLINICA CHIMICA ACTA, 2016, 459 : 109 - 116
[2] Alpha-1 Antitrypsin Therapy for Autoimmune Disorders
Song, Sihong
CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2018, 5 (04): : 289 - 301
[3] Alpha-1 antitrypsin: A novel biomarker and potential therapeutic approach for metabolic diseases
Zhang, Xiaojuan
Ostrov, David A.
Tian, Haoming
CLINICA CHIMICA ACTA, 2022, 534 : 71 - 76
[4] Gene therapy progress and prospects: Alpha-1 antitrypsin
Stecenko, AA
Brigham, KL
GENE THERAPY, 2003, 10 (02) : 95 - 99
[5] Gene Therapy Progress and Prospects: Alpha-1 antitrypsin
A A Stecenko
K L Brigham
Gene Therapy, 2003, 10 : 95 - 99
[6] New Therapeutic Targets for Alpha-1 Antitrypsin Deficiency
Lomas, David A.
CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2018, 5 (04): : 233 - 243
[7] Is There a Therapeutic Role for Selenium in Alpha-1 Antitrypsin Deficiency?
Greene, Catherine M.
Chhabra, Roohi
McElvaney, Noel G.
NUTRIENTS, 2013, 5 (03): : 758 - 770
[8] Therapeutic potential of alpha-1 antitrypsin in human disease
Kim, Minsun
Cai, Qing
Oh, Youngman
ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2018, 23 (03) : 131 - 135
[9] Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy
Wozniak, Joanna
Wandtke, Tomasz
Kopinski, Piotr
Chorostowska-Wynimko, Joanna
HUMAN GENE THERAPY, 2015, 26 (11) : 709 - 718
[10] Towards New Therapeutic Solutions for Alpha-1 Antitrypsin Deficiency: Role of the Alpha-1 Foundation
Wanner, Adam
CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2020, 7 (03): : 147 - 150

← 1 2 3 4 5 →